Olympics 2022 - What we know about Russian figure skater Kamila Valieva's alleged positive drug test

Russian figure skating sensation Kamila Valieva has reportedly tested positive for a banned drug. After the medal ceremony for the team figure skating event was postponed on Wednesday for what the International Olympic Committee called «legal issues,» Russian newspapers reported that Valieva had tested positive for trimetazidine, a drug usually used to treat heart-related chest pain.

What's next for Valieva? Will she be allowed to compete? What happens to the team event, where Russia won gold? While many questions remain, here's what we do — and don't know — so far.

Valieva, 15, is the brightest star on Russia's dominant figure skating team. In only her first senior season, she has won every competition she's entered and broken record after record. In the team event, she became the first woman to land a quadruple jump in Olympic competition and won both the women's short program and free skate to help Russia secure gold. She is widely expected to win a second gold medal in the women's singles competition, which begins next Tuesday.

In 2019, WADA banned Russia from international competition for four years due to a state-sponsored, years-long doping scheme involving some of the country's greatest athletes. But the ban, later reduced to two years, has been largely symbolic. Russian athletes have still been allowed to participate in the last three Olympics under a neutral flag. In fact, this year's Russian delegation of 214 athletes, competing as «Russian Olympic Committee,» is one of the largest in Beijing.

Trimetazidine, also known as TMZ, is a drug with stimulant properties normally used to treat angina, or chest pain due to reduced blood flow to the heart. It is not approved for use in the United States. The World